. (A) Alignment of S. cerevisiae Tfg2p with its human homolog RAP30. The PY-NLS is underlined and the PY motif is in bold. Identical residues are highlighted in black and similar residues in gray. Beta strands are represented by gray arrows and alpha helices by black bars. Secondary structure labels are from the RAP30 crystal (1f3u) and NMR structures (1bby). Asterisks denote residues mutated in the DNA binding domain. (B) Crystal structure of RAP74 (gray)/ RAP30 (blue) homodimerization domains. The PY-NLS insertion (red dashed line) is between RAP30 residues 88 and 89 (red solid line). 
Supplemental Methods
Cloning, protein expression and purification of Tfg2 DBDTfg2 DBD (284-365) was subcloned from the full length construct into the pGexTev vector. All point mutations were cloned using the QuikChange method (Stratagene) and confirmed by nucleotide sequencing. GST-DBD proteins were expressed and purified using the same method as GST-Kapβ. Gel filtration chromatography assay-5.2 nmol HIV-2 promoter DNA (GATATACCCG CTGCTC) (3) was subjected to gel filtration chromatography over a Superdex 75 (GE Healthcare) in the presence and absence of wild type and mutant Tfg2p DBD (1:2 DNA:DBD molar ratio). Absorbance was measured at 260 nm.
